SlideShare a Scribd company logo
1 of 6
Download to read offline
Journal of Pharmacy Research Vol.10 Issue 6 June 2016
V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436
431-436
Research Article
ISSN: 0974-6943
Available online through
http://jprsolutions.info
*Corresponding author.
Mr.V.Satyanarayana M.Pharm
Assistant Professor, Department of Pharmacy Practice,
Narasaraopeta Institute of Pharmaceutical Sciences,
Narasaraopet, Guntur(D.t), A.P. India-522601.
Evaluation of anti-arthritic activity of Polygonum glabrum
V.Satyanarayana1*
, S.JayaKumari2
1
Reasearch Scholar, VELs University, Pallavaram, Chennai, Tamilnadu, India-600117
2
Professor, Deapartment of Pharmacognosy, VELs University, Pallavaram, Chennai, Tamilnadu, India-600117
Received on:27-04-2016; Revised on: 21-05-2016; Accepted on: 19-06-2016
ABSTRACT
Background:The main objective ofthe study is to determine the anti-arthritic effect of whole plant ethanolic extract of Polygonum glabrum
belonging to the familyPolygonaceae in Female wistar rats using the Freund’s Complete Adjuvant (FCA) model . Methods:The plants areal
parts were collected near Tirupathi hills, Chittoor district of Andhra Pradesh in India. The Phytoconstituents were identified through the
chemical tests. Ethanol (95%) was used to obtain the whole plant extraction through Soxhlet extractor. Female SD rats were used for anti-
arthritic screening. Arthritis was induced using FCA, and the anti-arthritic effect of the ethanolic extract of P.glabrum was studied at doses
of250 and500 mg/kg. The effects were compared with those of indomethacin (10 mg/kg). At the end of the study, theliver enzyme levels were
determined and a radiological examination was carried out. Results and Discussion:The preliminaryphytochemical analysis of the ethanolic
extract of Polygonum glabrum showed the presence of alkaloids, tannins, flavonoids and saponins. P. glabrum at 250 and 500 mg/kg
significantlyinhibited the FCA-induced arthritis in the rats. This was manifested byas a decrease in the paw volume. The arthritic control
animals exhibited a significant decrease in bodyweight compared with control animals without arthritis. P. glabrum treated animals showed
dose dependent reduction in decrease in body weight and arthritis.At the same time, P.glabrum significantly altered the biochemical and
haematological changes induced by FCA (P < 0.05). The anti-arthritic effect of P.glabrum was comparable with that of Indomethacin.
Conclusion:The whole plant extract of P.glabrum showed significant anti-arthritic activityagainst FCA-induced arthritis in female Wistar
rats.
KEYWORDS :Antiarthritic activity, Ethanolic extract, Polygonum glabrum, FCA, wistar rats, Soxhlet extractor.
INTRODUCTION
Inflammatory diseases including different types of rheumatic
diseases are a major cause of morbidityof the working force through-
out World. This has been called the ‘King of Human Miseries’.
Although rheumatism is one of the oldest known diseases of the
mankind, it affects a large percentage of population of the world 1
.
Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune
disease, affecting freely movable joints, such as hand, knee and
shoulder joints. The symptoms of active RA include pain, swelling,
morning stiffness, warmth, redness, and limits in the functions ofthe
joints. The systemic ramifications of the disease, apart from
morbidity and mortality, include cardiopathy, nephropathy,
vasculopathy and pulmonary and cutaneous disorders Although
the cause of rheumatoid arthritis is unknown, autoimmunityplays a
pivotal role in both its chronicity and progression, and RA is consid-
ered as a systemic autoimmune disease.2
According to the WHO report, about 70–80% of the world’s popula-
tion rely on nonconventional medicine mainlyfrom herbal sources in
their primary health care. Especially, its demand is increasing dayby
day in developing countries where the cost of consulting a physi-
cian and price of medicine are beyond the limit of most people.3
A large number of plants/plant extracts/decoctions or pastes are
equallyused by tribal and folklore traditions in India for treatment of
pain. Present work to investigate the effect of Polygonumglabrum
compared with anti arthritic activity ofIndomethacin.4
MATERIALS AND METHODS
Collection and Authentication of plant material
The plants areal parts were collected near Tirupathi hills, Chittoor
district ofAndhra Pradesh in India.The collected plant material was
properlyidentified by theBotanist Prof. P. Jayaraman, PlantAnatomy
Journal of Pharmacy Research Vol.10 Issue 6 June 2016
V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436
431-436
Research Centre,Tambaram, Chennai.The plant parts were dried in
shade for 4-5 days and powdered.
Preparation of the plant extract
The whole plant powder was packed in a Soxhlet extractor and
extracted with 95% ethanol at 50°C.Extraction was carried out for 72
hours. The extract was filtered, and the filtrate was concentrated to a
dry mass. The yield was found to be 6.4% W/V. The extract was
stored in desiccators at room temperature until analysis.5,6
Phytochemical analysis
The ethanolic extract (500 mg) was dissolved in 100 ml of its own
mother solvent and used forphytochemical screening. The Salkowski
reaction, Liebermann’s reaction , the Libermann-Burchardreaction
(for detecting the presence of sterols), Dragendroff’s reaction,
Mayer’s test, Wagner’s test , Hager’s test (alkaloids), the ferric
chloride solution test, lead acetate test ,bromine water test
(tannins);the Keller-Kiliani test, Baljet’s test, Legal test (glycosides),
the Shinoda test and lead acetate test(flavonoids, phenolic
compounds and saponins) were carried out.7
Experimental animals:
Femalerats ofWistar strain weighing between 150-200gm were used
for the experiments. All the animals were obtained from National
Institute of Nutrition,Hyderabad and maintained in animal house of
department ofpharmacology, NARASARAOPETAINSTITUTE OF
PHARMACEUTICALSCIENCES, NARASARAOPET. All the pro-
tocols of animal experiments were approved by the Institutional
Animal Ethics Committee (Approval no-NIPS/1414/CPCSEA) in ac-
cordance to the guidelines of Committee for the Purpose of Control
and Supervision of Experiments on Animals(CPCSEA), ministryof
Social Justice and Empowerment, Government of India, NewDelhi.
The animals were housed in Poly propylene cages and maintained at
24°C ±2°C under 12 h light/ dark cycle and werefeededadlibitumwith
standard pellet diet and had free access to water.
Acute toxicity studies
Acute oral toxicity study of ethanolic extract of Polygonum
glabrumwas performed in line with OECD guidelines 423.
Anti-arthritis screening of Polygonum glabrum extract
Polygonum glabrumdoses were selected from previously published
reports(i.e.,250 and 500mg/kg).8,9
The extract was suspended in 0.5%
w/w carboxymethyl cellulose and administered orally.
The rats were divided into five groups of five animals each as fol-
lows.
Group-1: Vehicle control
Group-2: Arthritis control
Group-3: Polygonum glabrum250 mg/kg/day, p.o.
Group-4: Polygonum glabrum500 mg/kg/day, p.o.
Group-5: Indomethacin 10 mg/kg/day, p.o.
The method described by Newbould was employed with some
modifications.9
Adjuvant arthritis was induced by subcutaneous in-
jection of FCA (0.1 ml) (Difco Labs, Chennai) into the sub-plantar
tissue of the right hind paw of each rat. The test groups consisted of
FCA-injected rats challenged with their respective doses of the test
drug administered orally 24 hours before FCA injection. The vehicle
control rats were injected with 0.1 ml of liquid paraffin (Incomplete
Freund’sAdjuvant) only. The drug treatments were continued for 20
days after inducing arthritis.
The swelling in the injected paw and the contralateral hind paw were
monitored daily using a mercurydisplacement plethysmometer. The
increase in the extent of erythema and oedema of the tissue shows
the severity of the inflammation. The differences between the experi-
mental groups and the arthritis control group were statistically ana-
lyzed. The change in body weight was also recorded daily.10,11
Biochemical parameters
At the end of the study, blood samples were withdrawn from all
groups through retro-orbital plexus puncture, and the biochemical
parameters were analyzed.12
Haematological parameters such as the
hemoglobin (Hb) level, the red blood cell (RBC) count, the white
blood cell (WBC) count and the erythrocyte sedimentation rate (ESR)
were estimated manually. Liver markers such as SGOT and SGPT
were analyzed using an auto-analyzer (Vital Scientific N.V,
Netherlands). The liver enzyme levels were estimated using Lab Kit
enzymatic kits.
Radiographic analysis
At the end of the study, the animals were anaesthetized using
diethyl ether, and digital x-rays were taken for radiographic analysis
of the knee joints. X-raysweretaken ofthekneejoints for confirmation
and evaluation of the severity of arthritis in FCA-induced rats.
Statistical analysis
The mean ± SEM values were calculated for each group. Statistical
differences among the groupsweredeterminedusing one-wayANOVA
followed by Tukey’smultiplecomparison test. P <0.05was considered
to be significant.
RESULTS AND DISCUSSION:
The preliminary phytochemical analysis of the ethanolic extract of
Polygonum glabrum showed the presence of alkaloids, tannins,
flavonoids and saponins.
The arthritic control animals exhibited a significant decrease in body
weight compared with the control group. The results showed that
Indomethacin at 10 mg/kg and Polygonum glabrum at 250 mg/kg
and 500 mg/kg ameliorate the weight loss that occurs during arthritis
, these results are given in Table 1.
Journal of Pharmacy Research Vol.10 Issue 6 June 2016
V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436
431-436
As shown in Table 3, elevated SGOT and SGPT levels and reduced
RBC, ESR and Hb levels were observed in the arthritic controls
compared with the normal controls. Administration of the ethanolic
extract of Polygonum glabrumto arthritic rats (Group-3, Group-4,
Group-5) enhanced the Hb and RBC levels compared with the
arthritic control group.
Table 1: Effect of ethanolic extract of P.glabrumon Wrister Rat
growth
Group (n=5) Body Weight(Gm) Increase in
Initial Final Body Weight
(%)
Normal Control 180±1.52 191.286±2.284 6.271
Arthritis Control 185.20±1.72 192.2006±2.524 3.779
P.glabrum 250 mg/kg 175.92±1.20 185.666±1.7910 5.539
P.glabrum 500 mg/kg 182.13±1.25 191.7465±1.861 5.28
Indomethacin 10 mg/kg 162.24±0.36 174.4243±0.5473 7.51
Values expressed as Mean±SEM ; n=5 rats in each group
The latency of the arthritic secondary response ended after a few
days and was characterized by joint swelling and nodule events on
the 7 day. Administration of Polygonum glabrum(250 mg/kg) signifi-
cantly(P < 0.01) protected against joint swelling in paws in rats with
induced arthritis compared with the arthritis control group. But a
significant reduction was observed from day 11 to day 13 in the
Polygonum glabrum-treated (250 mg/kg) group.However, the effects
of Polygonum glabrumtreatment at 500 mg/kg were found to be
significant (P < 0.001) from the initial stage of the secondary
response and were maintained throughout the experiment. Theywere
significant (P0.01) 15-19 days after FCA injection compared with the
group treated with the reference standard, indomethacin at 10
mg/kg, these results are given in Table 2.
Table 2: Anti-arthritic activity of ethanolic extract of P.glabrum
compared with Indomethacin in injected paw(swelling volume.
[ml]±SEM
Treatment Post- Insult Time of Assay (Days)
1 3 5
Normal Control 0.14±0.00 0.11±0.0 0.11±0.0
Arthritis Control 0.76±0.00 0.87±0.0 1.07±0.0
P.glabrum 250 mg/kg 0.74±0.0 0.76±0.0 0.93±0.01
P.glabrum 500 mg/kg 0.68±0.0 0.81±0.0 0.95±0.01
Indomethacin (10 mg/kg) 0.64±0.0 0.74±0.0 0.85±0.00
7 9 11
Normal Control 0.11±0.0 0.11±0 0.11±0.0
Arthritis Control 1.21±0.0 0.95±0.0 0.87±0.01
P.glabrum 250 mg/kg 0.90±0.01 0.91±0.0 0.72±0.0
P.glabrum 500 mg/kg 0.88±0.01 0.85±0.0 0.82±0.0
Indomethacin (10 mg/kg) 0.79±0.0 0.79±0.0 0.67±0.0
13 15 17
Normal Control 0.11±0.0 0.11±0.0 0.11±0.0
Arthritis Control 0.87±0.0 0.88±.01 0.88±0.0
P.glabrum 250 mg/kg 0.68±0.01 0.71±0.01 0.75±0.01
P.glabrum 500 mg/kg 0.70±0.00 0.76±0.01 0.55±0.01
Indomethacin (10 mg/kg) 0.73±0.0 0.74±0.0 0.63±0.0
19 21
Normal Control 0.12±0.0 0.11±0.0
Arthritis Control 0.90±0.01 0.93±0.01
P.glabrum 250 mg/kg 069±0.0 0.77±0.01
P.glabrum 500 mg/kg 0.53±0.0 0.72±0.01
Indomethacin (10 mg/kg) 0.62±0.01 0.57±0.01
Values expressed as Mean±SEM ; n=5 rats in each group
Table 3: Effectof the ethanolic extract of P. glabrumonbiochemical
and hematological parameters
Group Biochemical Parameter
SGOT (U/L) SGPT (U/L)
Normal Control 103.26±0.15 53.58±0.62
Arthritis Control 230.68±1.86 148.52±1.62
P.glabrum 250 mg/kg 180.86±2.10 123.86±3.29
P.glabrum 500 mg/kg 139.81±2.57 110.54±1.09
Indomethacin (10 mg/kg) 126.25.±0.77 93.02±1.62
Hematological Parameter
WBC (c/cmm) RBC (m/cmm)
Normal Control 7.29±0.06 4.70±0.05
Arthritis Control 0.57±0.10 3.75±0.23
P.glabrum 250 mg/kg 7.15±0.03 4.79±0.22
P.glabrum 500 mg/kg 7.28±0.01 4.55±0.14
Indomethacin (10 mg/kg) 7.36±0.01 4.58±0.04
ESR (mm/Hr) Hb (gm/dl)
Normal Control 3.17±0.20 13.00±0.24
Arthritis Control 7.16±0.16 8.84±0.20
P.glabrum 250 mg/kg 5.27±0.15 9.52±0.11
P.glabrum 500 mg/kg 4.74±0.13 10.34±0.31
Indomethacin (10 mg/kg) 4.15±0.12 12.14±0.23
Values expressed as Mean±SEM ; n=5 rats in each group
Clinical analysis ofrheumatoidarthritisallowstherapeuticmonitoring,
which remains the standard method for evaluating the progress of
the disease. The loss of articular cartilage leads to diminished joint
spaces, which maybe brought about through a variety of pathological
mechanisms. The normal knee bone structure of normal control
animals may be seen in Figure 1. In contrast, the arthritis control
animals exhibit a loss of articular cartilage, severe soft tissue
swelling and reduced joint spaces. The degree of bone resorption,
diminution of joint spaces and swelling of tissue were markedly
reduced in Polygonum glabrum at 500 mg/kg. The lower dose of
Polygonum glabrum (250 mg/kg) produced similar results. The
standard drug, indomethacin, also produced fractional tibial
epiphysis, and the appearance of the femoral condyle was normal,
with no soft tissue swelling [Figure 1]. The animals treated with
Polygonum glabrum (500 mg/kg) and indomethacin showed a
significant decrease in paw oedema volume and increased joint
spaces compared with the arthritic control group.
Journal of Pharmacy Research Vol.10 Issue 6 June 2016
V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436
431-436
DISCUSSION
Polygonum glabrumat 250 and 500 mg/kg displayed significant anti-
arthritic activity, and the activity was comparable with that of in-
domethacin. Polygonum glabrum significantly increased the body
weight of animals compared with the arthritic controls. The anti-
arthritic activity of Polygonum glabrumis comparable with that of
the standard drug indomethacin.
There is increasing evidence that lysosomal enzymes playan impor-
tant role in the development of acute and chronic inflammations.13
Most of the anti-inflammatorydrugs exert their beneficial effects by
inhibiting the release of these enzymes, which is one of the inflam-
matoryprocesses, or bystabilizing the lysosomal membrane. So we
Fig 1. Normal control animal showing the normal knee
bonestructure
Fig 2.Animal withFCA-induced arthritis
Fig 3. Animal with FCA-inducedarthritis treated with P. glabrum,
Fig 4. Animal with FCA-inducedarthritis treated with P. glabrum,
Fig 5. Animal with FCA-inducedarthritis treated with indometha-
cin, 10 mg/kg, showing fractional tibialepiphysis
250mg/kg
500mg/kg
Journal of Pharmacy Research Vol.10 Issue 6 June 2016
V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436
431-436
can assume that our drug extract acts by inhibiting the lysosomal
enzymes or stabilizing the membrane.
The arthritic control animals showed marked increases in the levels
of the liver markers, whereas Polygonum glabrum inhibited the
increase in liver markers induced by FCA. Previous studies found
that FCA alsoalters thebiochemical and oxidative parameters.14
FCA-
induced arthritis is used to study the pathogenesis of
rheumatoidarthritis for testing therapeutics.15
One of the reasons for
the wide utilization of this model is a strong correlationbetween the
efficacyof therapeutic agents in this model and in rheumatoid arthri-
tis in humans, and this model ischaracterized bya very rapid erosive
disease. Bacterial peptidoglycan and muramyl dipeptide are respon-
sible forthe induction of adjuvant arthritis.
Changes in body weight have also been used to assess the course
of the disease and the response to therapy using anti-inflammatory
drugs. Adjuvant arthritis is characterized by reduced body weight,
and the weight loss is associated with an increased production of
pro-inflammatorycytokines such as TNF-α and interleukin-α. In the
present study, the arthritic rats exhibited a reduced RBC count,
reduced Hb level and increased ESR level.
All these symptoms indicate an anaemic condition, which is a
common diagnostic feature in patients with chronic arthritis. The
ESR is an estimate of the suspension stability of RBCs in plasma. It
is related to the number and size of the red blood cells and to the
relative concentration of plasma proteins, especially fibrinogen and
β globulins. An increase in the ESR is an indication of active but
obscure disease processes. The acute phase proteins in ESR
produce inflammation similar to that produced by an injection,
injury, surgery or tissue necrosis.
The treatment with Polygonum glabrum extract improved the RBC
count, Hb level and ESR to a near-normal level, indicating significant
recovery from the anaemic condition and arthritic progress, thus
establishing that the extract has a significant role in arthritic condi-
tions.
WBCs are a major component of the body’s immune system. Indica-
tions for a WBC count include infections and inflammatorydisease.
In arthritic conditions there is a mild to moderate rise in the WBC
count due to a release of IL-IB. IL-IB increases the production of
both granulocyte colonystimulating factor and macrophage colony
stimulating factor. The WBC count was increased in the arthritic
group. Migration of leukocytes produces a significant decrease in
the WBC count. Apart from prostaglandin, other cyclooxygenase
products and various cells involved in inflammatory changes and
free radical activities have all been implicated in the development of
rat adjuvant arthritis.
The radiographic analysis of the knee joint in the arthritic and drug-
treated animals further supported andconfirmed the potent dose-
dependent anti-arthritic effect of the ethanolic extract of Polygonum
glabrum ethanolic extract, which suppresses pathological changes,
such as pannus formation and bone destruction.
The antiarthritic effect of Polygonum glabrumis comparable with
that of indomethacin, and this action may be due to inhibition of the
enzyme cyclooxygenase. However, further studies are required to
confirm the effect of Polygonum glabrum on cyclooxygenase inhi-
bition.
Our phytochemical investigation revealed the presence of flavonoids.
Sterols are known to inhibit articular swelling, reduce the arthritis
index and down regulate the content ofIL-IB and TNF-in inflamed
tissues of arthritic rats.
CONCLUSION
The ethanolic whole plant extract of Polygonum glabrum exerts an
anti-arthritic activity by significantlyaltering the pathogenesis dur-
ing FCA-induced arthritis in female SD rats without exerting anyside
effects.
ACKNOWLEDGEMENTS
The author would like to thank Management, Principal, Teaching,
Non-teaching Staff of Narasaraopeta Institute of Pharmaceutical
Sciences, Narasaraopet, Guntur (D.t), A.P., India for providing sup-
port for successful completion of research work.
REFERENCES
1. Shah Biren N, Nayak BS, Seth AK, Jalalpure SS, Patel KN,
Patel MA and Mishra AD. Search for medicinal plants as a
source of anti-inflammatory and anti-arthritic agents - A
review. PharmacognosyMagazine, 2006; 2(6): 77-86.
2. G.S. Firestein,VIP: a veryimportant protein in arthritis, Natu-
ral Medicines, 7(2001), 537–538.
3. Amdekar S, RoyP, SinghV, KumarA, Singh Rand Sharma P.
Anti-Inflammatory Activity of Lactobacillus on Carrag-
eenan-Induced Paw Edema in male Wistar Rats. Interna-
tional Journal of Inflammation, 2012; 1-6.
4. Amritpal Singh, Samir Malhotra, Ravi subban,Anti- inflam-
matoryand analgesic agents from Indian medicinal plants,
International Journal ofintegrativeBiology, 2008(3):No.1,57.
5. Kumar EK, Masthan SK, Reddy KR, Reddy GA,
Raghunandan N, Chaitanya G. Anti-arthritic property of
the methanolic extract of Syzygium cumini seeds. Int J Integr
Biol.2008;4:55–61.
6. Kilimozhi D, Parthasarathy V, Amuthavalli N. Effect of
Clerodendrum phlomidis on adjuvant induced arthritis in
Journal of Pharmacy Research Vol.10 Issue 6 June 2016
V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436
431-436
Source of support: Nil, Conflict of interest: None Declared
rats:Aradiographic densitometric analysis. Int J Pharm Tech
Res. 2009;1:1434–41.
7. V Satyanarayana, S Jaya Kumari.Preliminaryphytochemical
screening and TLC profile ofselected four plants ofTirupati
hills in Chitoor district, Andhra Pradesh.Journal of
Pharmacognosyand Phytochemistry,2016:5(2):259-264
8. Bendele A, McComb J, Gould T, McAbee T, Sennello G,
Chlipala E, et al. Animal models of arthritis: Relevance to
human disease. ToxicolPathol. 1999;27:134–42.
9. Newbould BB. Suppression of adjuvant-induced arthritis
in rats with 2-butoxycarbonylmethylene-4- oxothiazolidine.
Br JPharmacol Chemother. 1965;24:632–40.
10. Bendele A. Animal models of rheumatoid arthritis. J
Musculoskelet Neuronal Interact. 2001;1:377–85.
11. Berrington J. Biologic treatments for rheumatoid arthritis.J
OrthopNurs. 2006;10:159–65.
12. Parasuraman S, Raveendran R, Kesavan R. Blood sample
collection in small laboratory animals. J Pharmacol
Pharmacother. 2010;1:87–93.
13. John NA, Shobana G.Anti-inflammatoryactivityofTalinum
fruticosum L. on formalin induced paw edema in albino rats.
JAppl Pharm Sci. 2012;2:123–7.
14. Kumar VL, RoyS. Calotropis procera latex extract affords
protection against inflammation and oxidative stress in
Freund’s complete adjuvant-induced monoarthritis in rats.
MediatorsInflamm. 2007;2007:47523.
15. Newbould BB. Chemotherapy ofarthritis induced in rats by
mycobacterial adjuvant. Br J Pharmacol Chemother.
1963;21:127–36.

More Related Content

What's hot

Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studies
KrushangiShah233
 

What's hot (20)

Safety Pharmacology | General Consideration | Safety Pharmacology Studies | G...
Safety Pharmacology | General Consideration | Safety Pharmacology Studies | G...Safety Pharmacology | General Consideration | Safety Pharmacology Studies | G...
Safety Pharmacology | General Consideration | Safety Pharmacology Studies | G...
 
CONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATIONCONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATION
 
Evaluation methods of anti-asthmatics
Evaluation methods of anti-asthmaticsEvaluation methods of anti-asthmatics
Evaluation methods of anti-asthmatics
 
SlideShare on Traditional drug design methods
 SlideShare on Traditional drug design methods  SlideShare on Traditional drug design methods
SlideShare on Traditional drug design methods
 
General principles of preclinical screening
General principles of preclinical screeningGeneral principles of preclinical screening
General principles of preclinical screening
 
hERG Assay
hERG Assay hERG Assay
hERG Assay
 
OECD Guidlines By Genotoxicity
OECD Guidlines By GenotoxicityOECD Guidlines By Genotoxicity
OECD Guidlines By Genotoxicity
 
Alternative methods to animal testing: review
Alternative methods to animal testing: reviewAlternative methods to animal testing: review
Alternative methods to animal testing: review
 
Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugs
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGS
 
Clinical trial study team
Clinical trial study teamClinical trial study team
Clinical trial study team
 
Clinical trial study team
Clinical trial study teamClinical trial study team
Clinical trial study team
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical Trials
 
A presentation on different phases of Clinical Trials, Investigational New Dr...
A presentation on different phases of Clinical Trials, Investigational New Dr...A presentation on different phases of Clinical Trials, Investigational New Dr...
A presentation on different phases of Clinical Trials, Investigational New Dr...
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studies
 
ind
indind
ind
 
Schedule Y
Schedule Y Schedule Y
Schedule Y
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
 
Schedule Y by akshdeep sharma
Schedule Y by akshdeep sharmaSchedule Y by akshdeep sharma
Schedule Y by akshdeep sharma
 

Viewers also liked

бейсенбаева альбина+ресторан+идея
бейсенбаева альбина+ресторан+идеябейсенбаева альбина+ресторан+идея
бейсенбаева альбина+ресторан+идея
Albina Beisenbaeva
 
Carbon TradeXchange Introduction - Broker
Carbon TradeXchange Introduction - BrokerCarbon TradeXchange Introduction - Broker
Carbon TradeXchange Introduction - Broker
Animesh Sourabh
 
Formulation Development and Evaluation of Risperidone Fast Dissolving Tablets
Formulation Development and Evaluation of Risperidone Fast Dissolving TabletsFormulation Development and Evaluation of Risperidone Fast Dissolving Tablets
Formulation Development and Evaluation of Risperidone Fast Dissolving Tablets
Dr. Raghavendra Kumar Gunda
 

Viewers also liked (16)

Modality as Contact Zone: The Convolution of Access, Politics, and Ethics in ...
Modality as Contact Zone: The Convolution of Access, Politics, and Ethics in ...Modality as Contact Zone: The Convolution of Access, Politics, and Ethics in ...
Modality as Contact Zone: The Convolution of Access, Politics, and Ethics in ...
 
Fungsi fungsi pada php - pemrograman php my sql
Fungsi fungsi pada php - pemrograman php my sqlFungsi fungsi pada php - pemrograman php my sql
Fungsi fungsi pada php - pemrograman php my sql
 
Report Writing
Report WritingReport Writing
Report Writing
 
ጣፋጭ ዜና መጽሄት ቁጥር 4 ቅፅ 2. ቁጥር 2 መጋቢት 2008
ጣፋጭ ዜና መጽሄት ቁጥር 4 ቅፅ 2. ቁጥር 2 መጋቢት 2008ጣፋጭ ዜና መጽሄት ቁጥር 4 ቅፅ 2. ቁጥር 2 መጋቢት 2008
ጣፋጭ ዜና መጽሄት ቁጥር 4 ቅፅ 2. ቁጥር 2 መጋቢት 2008
 
Identidad digital
Identidad digitalIdentidad digital
Identidad digital
 
бейсенбаева альбина+ресторан+идея
бейсенбаева альбина+ресторан+идеябейсенбаева альбина+ресторан+идея
бейсенбаева альбина+ресторан+идея
 
calentamiento global
calentamiento globalcalentamiento global
calentamiento global
 
Global witness
Global witnessGlobal witness
Global witness
 
Congreso de la Nacion
Congreso de la NacionCongreso de la Nacion
Congreso de la Nacion
 
Carbon TradeXchange Introduction - Broker
Carbon TradeXchange Introduction - BrokerCarbon TradeXchange Introduction - Broker
Carbon TradeXchange Introduction - Broker
 
menú sept 2016
menú sept 2016menú sept 2016
menú sept 2016
 
Prehistory didactic unit for David, our language assistant
Prehistory didactic unit for David, our language assistantPrehistory didactic unit for David, our language assistant
Prehistory didactic unit for David, our language assistant
 
Project lanjutan database bioskop
Project lanjutan database bioskopProject lanjutan database bioskop
Project lanjutan database bioskop
 
Formulation Development and Evaluation of Risperidone Fast Dissolving Tablets
Formulation Development and Evaluation of Risperidone Fast Dissolving TabletsFormulation Development and Evaluation of Risperidone Fast Dissolving Tablets
Formulation Development and Evaluation of Risperidone Fast Dissolving Tablets
 
Bécquer
BécquerBécquer
Bécquer
 
Modul 5
Modul 5Modul 5
Modul 5
 

Similar to Evaluation of anti-arthritic activity of Polygonum glabrum

Pharmacological evaluation of hepatoprotective activity of Ethanolic extract ...
Pharmacological evaluation of hepatoprotective activity of Ethanolic extract ...Pharmacological evaluation of hepatoprotective activity of Ethanolic extract ...
Pharmacological evaluation of hepatoprotective activity of Ethanolic extract ...
pharmaindexing
 
Evaluation of Antiurolithiatic Activity of Canthium dicoccum Ethanolic Extrac...
Evaluation of Antiurolithiatic Activity of Canthium dicoccum Ethanolic Extrac...Evaluation of Antiurolithiatic Activity of Canthium dicoccum Ethanolic Extrac...
Evaluation of Antiurolithiatic Activity of Canthium dicoccum Ethanolic Extrac...
gynomark
 
Evaluation of Antiulcer Activity of Extract of Calycophyllum Spruceanum (Bent...
Evaluation of Antiulcer Activity of Extract of Calycophyllum Spruceanum (Bent...Evaluation of Antiulcer Activity of Extract of Calycophyllum Spruceanum (Bent...
Evaluation of Antiulcer Activity of Extract of Calycophyllum Spruceanum (Bent...
gynomark
 
Antidiabetic and Cytoprotective Effect of Ethanolic Extract of SalaciaNitida ...
Antidiabetic and Cytoprotective Effect of Ethanolic Extract of SalaciaNitida ...Antidiabetic and Cytoprotective Effect of Ethanolic Extract of SalaciaNitida ...
Antidiabetic and Cytoprotective Effect of Ethanolic Extract of SalaciaNitida ...
IOSRJPBS
 
Effect of ethanol_stem_extract_of_homalium_letestui_on_histological_features_...
Effect of ethanol_stem_extract_of_homalium_letestui_on_histological_features_...Effect of ethanol_stem_extract_of_homalium_letestui_on_histological_features_...
Effect of ethanol_stem_extract_of_homalium_letestui_on_histological_features_...
oyepata
 
evaluation of hepatoprotective activity of bauhinia purpurea linn.pdf
evaluation of hepatoprotective activity of bauhinia purpurea linn.pdfevaluation of hepatoprotective activity of bauhinia purpurea linn.pdf
evaluation of hepatoprotective activity of bauhinia purpurea linn.pdf
gynomark
 
4.areca catechu in male rats
4.areca catechu in male rats4.areca catechu in male rats
4.areca catechu in male rats
rahma27aulia
 
SARCOSTEMMA ACIDUM
SARCOSTEMMA ACIDUMSARCOSTEMMA ACIDUM
SARCOSTEMMA ACIDUM
rahees555
 

Similar to Evaluation of anti-arthritic activity of Polygonum glabrum (20)

Evaluation of antiasthmatic activity of a polyherbal formulation containing f...
Evaluation of antiasthmatic activity of a polyherbal formulation containing f...Evaluation of antiasthmatic activity of a polyherbal formulation containing f...
Evaluation of antiasthmatic activity of a polyherbal formulation containing f...
 
Pharmacological evaluation of hepatoprotective activity of ethanolic extract ...
Pharmacological evaluation of hepatoprotective activity of ethanolic extract ...Pharmacological evaluation of hepatoprotective activity of ethanolic extract ...
Pharmacological evaluation of hepatoprotective activity of ethanolic extract ...
 
Pharmacological evaluation of hepatoprotective activity of Ethanolic extract ...
Pharmacological evaluation of hepatoprotective activity of Ethanolic extract ...Pharmacological evaluation of hepatoprotective activity of Ethanolic extract ...
Pharmacological evaluation of hepatoprotective activity of Ethanolic extract ...
 
MY Research
MY ResearchMY Research
MY Research
 
Garlic paper
Garlic paperGarlic paper
Garlic paper
 
Article wjpps 1454479295 (2)
Article wjpps 1454479295 (2)Article wjpps 1454479295 (2)
Article wjpps 1454479295 (2)
 
EVALUATION OF ANALGESIC AND ANTI-INFLAMMATORY.pdf
EVALUATION OF ANALGESIC AND ANTI-INFLAMMATORY.pdfEVALUATION OF ANALGESIC AND ANTI-INFLAMMATORY.pdf
EVALUATION OF ANALGESIC AND ANTI-INFLAMMATORY.pdf
 
Evaluation of Antiurolithiatic Activity of Canthium dicoccum Ethanolic Extrac...
Evaluation of Antiurolithiatic Activity of Canthium dicoccum Ethanolic Extrac...Evaluation of Antiurolithiatic Activity of Canthium dicoccum Ethanolic Extrac...
Evaluation of Antiurolithiatic Activity of Canthium dicoccum Ethanolic Extrac...
 
Evaluation of Antiulcer Activity of Extract of Calycophyllum Spruceanum (Bent...
Evaluation of Antiulcer Activity of Extract of Calycophyllum Spruceanum (Bent...Evaluation of Antiulcer Activity of Extract of Calycophyllum Spruceanum (Bent...
Evaluation of Antiulcer Activity of Extract of Calycophyllum Spruceanum (Bent...
 
Antidiabetic and Cytoprotective Effect of Ethanolic Extract of SalaciaNitida ...
Antidiabetic and Cytoprotective Effect of Ethanolic Extract of SalaciaNitida ...Antidiabetic and Cytoprotective Effect of Ethanolic Extract of SalaciaNitida ...
Antidiabetic and Cytoprotective Effect of Ethanolic Extract of SalaciaNitida ...
 
Effect of ethanol_stem_extract_of_homalium_letestui_on_histological_features_...
Effect of ethanol_stem_extract_of_homalium_letestui_on_histological_features_...Effect of ethanol_stem_extract_of_homalium_letestui_on_histological_features_...
Effect of ethanol_stem_extract_of_homalium_letestui_on_histological_features_...
 
evaluation of hepatoprotective activity of bauhinia purpurea linn.pdf
evaluation of hepatoprotective activity of bauhinia purpurea linn.pdfevaluation of hepatoprotective activity of bauhinia purpurea linn.pdf
evaluation of hepatoprotective activity of bauhinia purpurea linn.pdf
 
4.areca catechu in male rats
4.areca catechu in male rats4.areca catechu in male rats
4.areca catechu in male rats
 
OTA #01877
OTA #01877OTA #01877
OTA #01877
 
Hepatoprotective activity of actinopteris radiata linn
Hepatoprotective activity of actinopteris radiata linnHepatoprotective activity of actinopteris radiata linn
Hepatoprotective activity of actinopteris radiata linn
 
SARCOSTEMMA ACIDUM
SARCOSTEMMA ACIDUMSARCOSTEMMA ACIDUM
SARCOSTEMMA ACIDUM
 
Pharmacological and phytochemical investigation of Cestrum nocturnum leaf ext...
Pharmacological and phytochemical investigation of Cestrum nocturnum leaf ext...Pharmacological and phytochemical investigation of Cestrum nocturnum leaf ext...
Pharmacological and phytochemical investigation of Cestrum nocturnum leaf ext...
 
Hepatoprotective Activity of Methanolic Extract of Whole Plant of Pulicaria W...
Hepatoprotective Activity of Methanolic Extract of Whole Plant of Pulicaria W...Hepatoprotective Activity of Methanolic Extract of Whole Plant of Pulicaria W...
Hepatoprotective Activity of Methanolic Extract of Whole Plant of Pulicaria W...
 
cgt201624a
cgt201624acgt201624a
cgt201624a
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
 

More from Dr. Raghavendra Kumar Gunda

A statistical study on the formulation development of sustained release table...
A statistical study on the formulation development of sustained release table...A statistical study on the formulation development of sustained release table...
A statistical study on the formulation development of sustained release table...
Dr. Raghavendra Kumar Gunda
 
DESIGN, DEVELOPMENT AND EVALUATION OF LABETALOL HCl GASTRO RETENTIVE FLOATING...
DESIGN, DEVELOPMENT AND EVALUATION OF LABETALOL HCl GASTRO RETENTIVE FLOATING...DESIGN, DEVELOPMENT AND EVALUATION OF LABETALOL HCl GASTRO RETENTIVE FLOATING...
DESIGN, DEVELOPMENT AND EVALUATION OF LABETALOL HCl GASTRO RETENTIVE FLOATING...
Dr. Raghavendra Kumar Gunda
 
DESIGN, FORMULATION AND IN VITRO EVALUATION OF TELMISARTAN SUSTAINED RELEASE ...
DESIGN, FORMULATION AND IN VITRO EVALUATION OF TELMISARTAN SUSTAINED RELEASE ...DESIGN, FORMULATION AND IN VITRO EVALUATION OF TELMISARTAN SUSTAINED RELEASE ...
DESIGN, FORMULATION AND IN VITRO EVALUATION OF TELMISARTAN SUSTAINED RELEASE ...
Dr. Raghavendra Kumar Gunda
 
Design, development, and in vitro evaluation of sustained release tablet form...
Design, development, and in vitro evaluation of sustained release tablet form...Design, development, and in vitro evaluation of sustained release tablet form...
Design, development, and in vitro evaluation of sustained release tablet form...
Dr. Raghavendra Kumar Gunda
 
Formulation Development and Evaluation of Amisulpride Fast Dissolving Tablets
Formulation Development and Evaluation of Amisulpride Fast Dissolving TabletsFormulation Development and Evaluation of Amisulpride Fast Dissolving Tablets
Formulation Development and Evaluation of Amisulpride Fast Dissolving Tablets
Dr. Raghavendra Kumar Gunda
 
Design, formulation, and in vitro evaluation of sustained release tablets for...
Design, formulation, and in vitro evaluation of sustained release tablets for...Design, formulation, and in vitro evaluation of sustained release tablets for...
Design, formulation, and in vitro evaluation of sustained release tablets for...
Dr. Raghavendra Kumar Gunda
 
Formulation Development And Evaluation Of Simvastatin Sustained Release Tablets
Formulation Development And Evaluation Of Simvastatin Sustained Release TabletsFormulation Development And Evaluation Of Simvastatin Sustained Release Tablets
Formulation Development And Evaluation Of Simvastatin Sustained Release Tablets
Dr. Raghavendra Kumar Gunda
 
Formulation Development and Evaluation of Doxofylline Sustained Release Tablets
Formulation Development and Evaluation of Doxofylline Sustained Release TabletsFormulation Development and Evaluation of Doxofylline Sustained Release Tablets
Formulation Development and Evaluation of Doxofylline Sustained Release Tablets
Dr. Raghavendra Kumar Gunda
 
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKECOST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
Dr. Raghavendra Kumar Gunda
 
Formulation Development and Evaluation of Gastro Retentive Drug Delivery Syst...
Formulation Development and Evaluation of Gastro Retentive Drug Delivery Syst...Formulation Development and Evaluation of Gastro Retentive Drug Delivery Syst...
Formulation Development and Evaluation of Gastro Retentive Drug Delivery Syst...
Dr. Raghavendra Kumar Gunda
 
Formulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Formulation Development and Evaluation of Clopidogrel Fast Dissolving TabletsFormulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Formulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Dr. Raghavendra Kumar Gunda
 
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving TabletsFormulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Dr. Raghavendra Kumar Gunda
 
Formulation design, optimization and evaluation of domperidone maleate gastro...
Formulation design, optimization and evaluation of domperidone maleate gastro...Formulation design, optimization and evaluation of domperidone maleate gastro...
Formulation design, optimization and evaluation of domperidone maleate gastro...
Dr. Raghavendra Kumar Gunda
 

More from Dr. Raghavendra Kumar Gunda (20)

A statistical study on the formulation development of sustained release table...
A statistical study on the formulation development of sustained release table...A statistical study on the formulation development of sustained release table...
A statistical study on the formulation development of sustained release table...
 
DESIGN, DEVELOPMENT AND EVALUATION OF LABETALOL HCl GASTRO RETENTIVE FLOATING...
DESIGN, DEVELOPMENT AND EVALUATION OF LABETALOL HCl GASTRO RETENTIVE FLOATING...DESIGN, DEVELOPMENT AND EVALUATION OF LABETALOL HCl GASTRO RETENTIVE FLOATING...
DESIGN, DEVELOPMENT AND EVALUATION OF LABETALOL HCl GASTRO RETENTIVE FLOATING...
 
DESIGN, FORMULATION AND IN VITRO EVALUATION OF TELMISARTAN SUSTAINED RELEASE ...
DESIGN, FORMULATION AND IN VITRO EVALUATION OF TELMISARTAN SUSTAINED RELEASE ...DESIGN, FORMULATION AND IN VITRO EVALUATION OF TELMISARTAN SUSTAINED RELEASE ...
DESIGN, FORMULATION AND IN VITRO EVALUATION OF TELMISARTAN SUSTAINED RELEASE ...
 
Design, development, and in vitro evaluation of sustained release tablet form...
Design, development, and in vitro evaluation of sustained release tablet form...Design, development, and in vitro evaluation of sustained release tablet form...
Design, development, and in vitro evaluation of sustained release tablet form...
 
Formulation Development and Evaluation of Amisulpride Fast Dissolving Tablets
Formulation Development and Evaluation of Amisulpride Fast Dissolving TabletsFormulation Development and Evaluation of Amisulpride Fast Dissolving Tablets
Formulation Development and Evaluation of Amisulpride Fast Dissolving Tablets
 
Design, formulation, and in vitro evaluation of sustained release tablets for...
Design, formulation, and in vitro evaluation of sustained release tablets for...Design, formulation, and in vitro evaluation of sustained release tablets for...
Design, formulation, and in vitro evaluation of sustained release tablets for...
 
Formulation Development And Evaluation Of Simvastatin Sustained Release Tablets
Formulation Development And Evaluation Of Simvastatin Sustained Release TabletsFormulation Development And Evaluation Of Simvastatin Sustained Release Tablets
Formulation Development And Evaluation Of Simvastatin Sustained Release Tablets
 
Formulation Development and Evaluation of Doxofylline Sustained Release Tablets
Formulation Development and Evaluation of Doxofylline Sustained Release TabletsFormulation Development and Evaluation of Doxofylline Sustained Release Tablets
Formulation Development and Evaluation of Doxofylline Sustained Release Tablets
 
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKECOST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
 
Formulation Development and Evaluation of Gastro Retentive Drug Delivery Syst...
Formulation Development and Evaluation of Gastro Retentive Drug Delivery Syst...Formulation Development and Evaluation of Gastro Retentive Drug Delivery Syst...
Formulation Development and Evaluation of Gastro Retentive Drug Delivery Syst...
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Drug Interactions and Adverse drug Reactions
Drug Interactions and Adverse drug ReactionsDrug Interactions and Adverse drug Reactions
Drug Interactions and Adverse drug Reactions
 
Formulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Formulation Development and Evaluation of Clopidogrel Fast Dissolving TabletsFormulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Formulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
 
ANTIDEPRESSANTS IN CHRONIC PAIN RELIEF- A REVIEW
ANTIDEPRESSANTS IN CHRONIC PAIN RELIEF- A REVIEWANTIDEPRESSANTS IN CHRONIC PAIN RELIEF- A REVIEW
ANTIDEPRESSANTS IN CHRONIC PAIN RELIEF- A REVIEW
 
Potentiality of a newer oral Anti hyperglycemic combination therapy over conv...
Potentiality of a newer oral Anti hyperglycemic combination therapy over conv...Potentiality of a newer oral Anti hyperglycemic combination therapy over conv...
Potentiality of a newer oral Anti hyperglycemic combination therapy over conv...
 
A RARE CASE OF GARLIC INDUCED HYPERSENSITIVITY REACTION
A RARE CASE OF GARLIC INDUCED HYPERSENSITIVITY REACTIONA RARE CASE OF GARLIC INDUCED HYPERSENSITIVITY REACTION
A RARE CASE OF GARLIC INDUCED HYPERSENSITIVITY REACTION
 
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving TabletsFormulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
 
04_AJP_460_15_OA_20151231_V1
04_AJP_460_15_OA_20151231_V104_AJP_460_15_OA_20151231_V1
04_AJP_460_15_OA_20151231_V1
 
SATHISH PH.COLOGY ARTICLE
SATHISH PH.COLOGY ARTICLESATHISH PH.COLOGY ARTICLE
SATHISH PH.COLOGY ARTICLE
 
Formulation design, optimization and evaluation of domperidone maleate gastro...
Formulation design, optimization and evaluation of domperidone maleate gastro...Formulation design, optimization and evaluation of domperidone maleate gastro...
Formulation design, optimization and evaluation of domperidone maleate gastro...
 

Recently uploaded

Recently uploaded (20)

Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 

Evaluation of anti-arthritic activity of Polygonum glabrum

  • 1. Journal of Pharmacy Research Vol.10 Issue 6 June 2016 V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436 431-436 Research Article ISSN: 0974-6943 Available online through http://jprsolutions.info *Corresponding author. Mr.V.Satyanarayana M.Pharm Assistant Professor, Department of Pharmacy Practice, Narasaraopeta Institute of Pharmaceutical Sciences, Narasaraopet, Guntur(D.t), A.P. India-522601. Evaluation of anti-arthritic activity of Polygonum glabrum V.Satyanarayana1* , S.JayaKumari2 1 Reasearch Scholar, VELs University, Pallavaram, Chennai, Tamilnadu, India-600117 2 Professor, Deapartment of Pharmacognosy, VELs University, Pallavaram, Chennai, Tamilnadu, India-600117 Received on:27-04-2016; Revised on: 21-05-2016; Accepted on: 19-06-2016 ABSTRACT Background:The main objective ofthe study is to determine the anti-arthritic effect of whole plant ethanolic extract of Polygonum glabrum belonging to the familyPolygonaceae in Female wistar rats using the Freund’s Complete Adjuvant (FCA) model . Methods:The plants areal parts were collected near Tirupathi hills, Chittoor district of Andhra Pradesh in India. The Phytoconstituents were identified through the chemical tests. Ethanol (95%) was used to obtain the whole plant extraction through Soxhlet extractor. Female SD rats were used for anti- arthritic screening. Arthritis was induced using FCA, and the anti-arthritic effect of the ethanolic extract of P.glabrum was studied at doses of250 and500 mg/kg. The effects were compared with those of indomethacin (10 mg/kg). At the end of the study, theliver enzyme levels were determined and a radiological examination was carried out. Results and Discussion:The preliminaryphytochemical analysis of the ethanolic extract of Polygonum glabrum showed the presence of alkaloids, tannins, flavonoids and saponins. P. glabrum at 250 and 500 mg/kg significantlyinhibited the FCA-induced arthritis in the rats. This was manifested byas a decrease in the paw volume. The arthritic control animals exhibited a significant decrease in bodyweight compared with control animals without arthritis. P. glabrum treated animals showed dose dependent reduction in decrease in body weight and arthritis.At the same time, P.glabrum significantly altered the biochemical and haematological changes induced by FCA (P < 0.05). The anti-arthritic effect of P.glabrum was comparable with that of Indomethacin. Conclusion:The whole plant extract of P.glabrum showed significant anti-arthritic activityagainst FCA-induced arthritis in female Wistar rats. KEYWORDS :Antiarthritic activity, Ethanolic extract, Polygonum glabrum, FCA, wistar rats, Soxhlet extractor. INTRODUCTION Inflammatory diseases including different types of rheumatic diseases are a major cause of morbidityof the working force through- out World. This has been called the ‘King of Human Miseries’. Although rheumatism is one of the oldest known diseases of the mankind, it affects a large percentage of population of the world 1 . Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease, affecting freely movable joints, such as hand, knee and shoulder joints. The symptoms of active RA include pain, swelling, morning stiffness, warmth, redness, and limits in the functions ofthe joints. The systemic ramifications of the disease, apart from morbidity and mortality, include cardiopathy, nephropathy, vasculopathy and pulmonary and cutaneous disorders Although the cause of rheumatoid arthritis is unknown, autoimmunityplays a pivotal role in both its chronicity and progression, and RA is consid- ered as a systemic autoimmune disease.2 According to the WHO report, about 70–80% of the world’s popula- tion rely on nonconventional medicine mainlyfrom herbal sources in their primary health care. Especially, its demand is increasing dayby day in developing countries where the cost of consulting a physi- cian and price of medicine are beyond the limit of most people.3 A large number of plants/plant extracts/decoctions or pastes are equallyused by tribal and folklore traditions in India for treatment of pain. Present work to investigate the effect of Polygonumglabrum compared with anti arthritic activity ofIndomethacin.4 MATERIALS AND METHODS Collection and Authentication of plant material The plants areal parts were collected near Tirupathi hills, Chittoor district ofAndhra Pradesh in India.The collected plant material was properlyidentified by theBotanist Prof. P. Jayaraman, PlantAnatomy
  • 2. Journal of Pharmacy Research Vol.10 Issue 6 June 2016 V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436 431-436 Research Centre,Tambaram, Chennai.The plant parts were dried in shade for 4-5 days and powdered. Preparation of the plant extract The whole plant powder was packed in a Soxhlet extractor and extracted with 95% ethanol at 50°C.Extraction was carried out for 72 hours. The extract was filtered, and the filtrate was concentrated to a dry mass. The yield was found to be 6.4% W/V. The extract was stored in desiccators at room temperature until analysis.5,6 Phytochemical analysis The ethanolic extract (500 mg) was dissolved in 100 ml of its own mother solvent and used forphytochemical screening. The Salkowski reaction, Liebermann’s reaction , the Libermann-Burchardreaction (for detecting the presence of sterols), Dragendroff’s reaction, Mayer’s test, Wagner’s test , Hager’s test (alkaloids), the ferric chloride solution test, lead acetate test ,bromine water test (tannins);the Keller-Kiliani test, Baljet’s test, Legal test (glycosides), the Shinoda test and lead acetate test(flavonoids, phenolic compounds and saponins) were carried out.7 Experimental animals: Femalerats ofWistar strain weighing between 150-200gm were used for the experiments. All the animals were obtained from National Institute of Nutrition,Hyderabad and maintained in animal house of department ofpharmacology, NARASARAOPETAINSTITUTE OF PHARMACEUTICALSCIENCES, NARASARAOPET. All the pro- tocols of animal experiments were approved by the Institutional Animal Ethics Committee (Approval no-NIPS/1414/CPCSEA) in ac- cordance to the guidelines of Committee for the Purpose of Control and Supervision of Experiments on Animals(CPCSEA), ministryof Social Justice and Empowerment, Government of India, NewDelhi. The animals were housed in Poly propylene cages and maintained at 24°C ±2°C under 12 h light/ dark cycle and werefeededadlibitumwith standard pellet diet and had free access to water. Acute toxicity studies Acute oral toxicity study of ethanolic extract of Polygonum glabrumwas performed in line with OECD guidelines 423. Anti-arthritis screening of Polygonum glabrum extract Polygonum glabrumdoses were selected from previously published reports(i.e.,250 and 500mg/kg).8,9 The extract was suspended in 0.5% w/w carboxymethyl cellulose and administered orally. The rats were divided into five groups of five animals each as fol- lows. Group-1: Vehicle control Group-2: Arthritis control Group-3: Polygonum glabrum250 mg/kg/day, p.o. Group-4: Polygonum glabrum500 mg/kg/day, p.o. Group-5: Indomethacin 10 mg/kg/day, p.o. The method described by Newbould was employed with some modifications.9 Adjuvant arthritis was induced by subcutaneous in- jection of FCA (0.1 ml) (Difco Labs, Chennai) into the sub-plantar tissue of the right hind paw of each rat. The test groups consisted of FCA-injected rats challenged with their respective doses of the test drug administered orally 24 hours before FCA injection. The vehicle control rats were injected with 0.1 ml of liquid paraffin (Incomplete Freund’sAdjuvant) only. The drug treatments were continued for 20 days after inducing arthritis. The swelling in the injected paw and the contralateral hind paw were monitored daily using a mercurydisplacement plethysmometer. The increase in the extent of erythema and oedema of the tissue shows the severity of the inflammation. The differences between the experi- mental groups and the arthritis control group were statistically ana- lyzed. The change in body weight was also recorded daily.10,11 Biochemical parameters At the end of the study, blood samples were withdrawn from all groups through retro-orbital plexus puncture, and the biochemical parameters were analyzed.12 Haematological parameters such as the hemoglobin (Hb) level, the red blood cell (RBC) count, the white blood cell (WBC) count and the erythrocyte sedimentation rate (ESR) were estimated manually. Liver markers such as SGOT and SGPT were analyzed using an auto-analyzer (Vital Scientific N.V, Netherlands). The liver enzyme levels were estimated using Lab Kit enzymatic kits. Radiographic analysis At the end of the study, the animals were anaesthetized using diethyl ether, and digital x-rays were taken for radiographic analysis of the knee joints. X-raysweretaken ofthekneejoints for confirmation and evaluation of the severity of arthritis in FCA-induced rats. Statistical analysis The mean ± SEM values were calculated for each group. Statistical differences among the groupsweredeterminedusing one-wayANOVA followed by Tukey’smultiplecomparison test. P <0.05was considered to be significant. RESULTS AND DISCUSSION: The preliminary phytochemical analysis of the ethanolic extract of Polygonum glabrum showed the presence of alkaloids, tannins, flavonoids and saponins. The arthritic control animals exhibited a significant decrease in body weight compared with the control group. The results showed that Indomethacin at 10 mg/kg and Polygonum glabrum at 250 mg/kg and 500 mg/kg ameliorate the weight loss that occurs during arthritis , these results are given in Table 1.
  • 3. Journal of Pharmacy Research Vol.10 Issue 6 June 2016 V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436 431-436 As shown in Table 3, elevated SGOT and SGPT levels and reduced RBC, ESR and Hb levels were observed in the arthritic controls compared with the normal controls. Administration of the ethanolic extract of Polygonum glabrumto arthritic rats (Group-3, Group-4, Group-5) enhanced the Hb and RBC levels compared with the arthritic control group. Table 1: Effect of ethanolic extract of P.glabrumon Wrister Rat growth Group (n=5) Body Weight(Gm) Increase in Initial Final Body Weight (%) Normal Control 180±1.52 191.286±2.284 6.271 Arthritis Control 185.20±1.72 192.2006±2.524 3.779 P.glabrum 250 mg/kg 175.92±1.20 185.666±1.7910 5.539 P.glabrum 500 mg/kg 182.13±1.25 191.7465±1.861 5.28 Indomethacin 10 mg/kg 162.24±0.36 174.4243±0.5473 7.51 Values expressed as Mean±SEM ; n=5 rats in each group The latency of the arthritic secondary response ended after a few days and was characterized by joint swelling and nodule events on the 7 day. Administration of Polygonum glabrum(250 mg/kg) signifi- cantly(P < 0.01) protected against joint swelling in paws in rats with induced arthritis compared with the arthritis control group. But a significant reduction was observed from day 11 to day 13 in the Polygonum glabrum-treated (250 mg/kg) group.However, the effects of Polygonum glabrumtreatment at 500 mg/kg were found to be significant (P < 0.001) from the initial stage of the secondary response and were maintained throughout the experiment. Theywere significant (P0.01) 15-19 days after FCA injection compared with the group treated with the reference standard, indomethacin at 10 mg/kg, these results are given in Table 2. Table 2: Anti-arthritic activity of ethanolic extract of P.glabrum compared with Indomethacin in injected paw(swelling volume. [ml]±SEM Treatment Post- Insult Time of Assay (Days) 1 3 5 Normal Control 0.14±0.00 0.11±0.0 0.11±0.0 Arthritis Control 0.76±0.00 0.87±0.0 1.07±0.0 P.glabrum 250 mg/kg 0.74±0.0 0.76±0.0 0.93±0.01 P.glabrum 500 mg/kg 0.68±0.0 0.81±0.0 0.95±0.01 Indomethacin (10 mg/kg) 0.64±0.0 0.74±0.0 0.85±0.00 7 9 11 Normal Control 0.11±0.0 0.11±0 0.11±0.0 Arthritis Control 1.21±0.0 0.95±0.0 0.87±0.01 P.glabrum 250 mg/kg 0.90±0.01 0.91±0.0 0.72±0.0 P.glabrum 500 mg/kg 0.88±0.01 0.85±0.0 0.82±0.0 Indomethacin (10 mg/kg) 0.79±0.0 0.79±0.0 0.67±0.0 13 15 17 Normal Control 0.11±0.0 0.11±0.0 0.11±0.0 Arthritis Control 0.87±0.0 0.88±.01 0.88±0.0 P.glabrum 250 mg/kg 0.68±0.01 0.71±0.01 0.75±0.01 P.glabrum 500 mg/kg 0.70±0.00 0.76±0.01 0.55±0.01 Indomethacin (10 mg/kg) 0.73±0.0 0.74±0.0 0.63±0.0 19 21 Normal Control 0.12±0.0 0.11±0.0 Arthritis Control 0.90±0.01 0.93±0.01 P.glabrum 250 mg/kg 069±0.0 0.77±0.01 P.glabrum 500 mg/kg 0.53±0.0 0.72±0.01 Indomethacin (10 mg/kg) 0.62±0.01 0.57±0.01 Values expressed as Mean±SEM ; n=5 rats in each group Table 3: Effectof the ethanolic extract of P. glabrumonbiochemical and hematological parameters Group Biochemical Parameter SGOT (U/L) SGPT (U/L) Normal Control 103.26±0.15 53.58±0.62 Arthritis Control 230.68±1.86 148.52±1.62 P.glabrum 250 mg/kg 180.86±2.10 123.86±3.29 P.glabrum 500 mg/kg 139.81±2.57 110.54±1.09 Indomethacin (10 mg/kg) 126.25.±0.77 93.02±1.62 Hematological Parameter WBC (c/cmm) RBC (m/cmm) Normal Control 7.29±0.06 4.70±0.05 Arthritis Control 0.57±0.10 3.75±0.23 P.glabrum 250 mg/kg 7.15±0.03 4.79±0.22 P.glabrum 500 mg/kg 7.28±0.01 4.55±0.14 Indomethacin (10 mg/kg) 7.36±0.01 4.58±0.04 ESR (mm/Hr) Hb (gm/dl) Normal Control 3.17±0.20 13.00±0.24 Arthritis Control 7.16±0.16 8.84±0.20 P.glabrum 250 mg/kg 5.27±0.15 9.52±0.11 P.glabrum 500 mg/kg 4.74±0.13 10.34±0.31 Indomethacin (10 mg/kg) 4.15±0.12 12.14±0.23 Values expressed as Mean±SEM ; n=5 rats in each group Clinical analysis ofrheumatoidarthritisallowstherapeuticmonitoring, which remains the standard method for evaluating the progress of the disease. The loss of articular cartilage leads to diminished joint spaces, which maybe brought about through a variety of pathological mechanisms. The normal knee bone structure of normal control animals may be seen in Figure 1. In contrast, the arthritis control animals exhibit a loss of articular cartilage, severe soft tissue swelling and reduced joint spaces. The degree of bone resorption, diminution of joint spaces and swelling of tissue were markedly reduced in Polygonum glabrum at 500 mg/kg. The lower dose of Polygonum glabrum (250 mg/kg) produced similar results. The standard drug, indomethacin, also produced fractional tibial epiphysis, and the appearance of the femoral condyle was normal, with no soft tissue swelling [Figure 1]. The animals treated with Polygonum glabrum (500 mg/kg) and indomethacin showed a significant decrease in paw oedema volume and increased joint spaces compared with the arthritic control group.
  • 4. Journal of Pharmacy Research Vol.10 Issue 6 June 2016 V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436 431-436 DISCUSSION Polygonum glabrumat 250 and 500 mg/kg displayed significant anti- arthritic activity, and the activity was comparable with that of in- domethacin. Polygonum glabrum significantly increased the body weight of animals compared with the arthritic controls. The anti- arthritic activity of Polygonum glabrumis comparable with that of the standard drug indomethacin. There is increasing evidence that lysosomal enzymes playan impor- tant role in the development of acute and chronic inflammations.13 Most of the anti-inflammatorydrugs exert their beneficial effects by inhibiting the release of these enzymes, which is one of the inflam- matoryprocesses, or bystabilizing the lysosomal membrane. So we Fig 1. Normal control animal showing the normal knee bonestructure Fig 2.Animal withFCA-induced arthritis Fig 3. Animal with FCA-inducedarthritis treated with P. glabrum, Fig 4. Animal with FCA-inducedarthritis treated with P. glabrum, Fig 5. Animal with FCA-inducedarthritis treated with indometha- cin, 10 mg/kg, showing fractional tibialepiphysis 250mg/kg 500mg/kg
  • 5. Journal of Pharmacy Research Vol.10 Issue 6 June 2016 V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436 431-436 can assume that our drug extract acts by inhibiting the lysosomal enzymes or stabilizing the membrane. The arthritic control animals showed marked increases in the levels of the liver markers, whereas Polygonum glabrum inhibited the increase in liver markers induced by FCA. Previous studies found that FCA alsoalters thebiochemical and oxidative parameters.14 FCA- induced arthritis is used to study the pathogenesis of rheumatoidarthritis for testing therapeutics.15 One of the reasons for the wide utilization of this model is a strong correlationbetween the efficacyof therapeutic agents in this model and in rheumatoid arthri- tis in humans, and this model ischaracterized bya very rapid erosive disease. Bacterial peptidoglycan and muramyl dipeptide are respon- sible forthe induction of adjuvant arthritis. Changes in body weight have also been used to assess the course of the disease and the response to therapy using anti-inflammatory drugs. Adjuvant arthritis is characterized by reduced body weight, and the weight loss is associated with an increased production of pro-inflammatorycytokines such as TNF-α and interleukin-α. In the present study, the arthritic rats exhibited a reduced RBC count, reduced Hb level and increased ESR level. All these symptoms indicate an anaemic condition, which is a common diagnostic feature in patients with chronic arthritis. The ESR is an estimate of the suspension stability of RBCs in plasma. It is related to the number and size of the red blood cells and to the relative concentration of plasma proteins, especially fibrinogen and β globulins. An increase in the ESR is an indication of active but obscure disease processes. The acute phase proteins in ESR produce inflammation similar to that produced by an injection, injury, surgery or tissue necrosis. The treatment with Polygonum glabrum extract improved the RBC count, Hb level and ESR to a near-normal level, indicating significant recovery from the anaemic condition and arthritic progress, thus establishing that the extract has a significant role in arthritic condi- tions. WBCs are a major component of the body’s immune system. Indica- tions for a WBC count include infections and inflammatorydisease. In arthritic conditions there is a mild to moderate rise in the WBC count due to a release of IL-IB. IL-IB increases the production of both granulocyte colonystimulating factor and macrophage colony stimulating factor. The WBC count was increased in the arthritic group. Migration of leukocytes produces a significant decrease in the WBC count. Apart from prostaglandin, other cyclooxygenase products and various cells involved in inflammatory changes and free radical activities have all been implicated in the development of rat adjuvant arthritis. The radiographic analysis of the knee joint in the arthritic and drug- treated animals further supported andconfirmed the potent dose- dependent anti-arthritic effect of the ethanolic extract of Polygonum glabrum ethanolic extract, which suppresses pathological changes, such as pannus formation and bone destruction. The antiarthritic effect of Polygonum glabrumis comparable with that of indomethacin, and this action may be due to inhibition of the enzyme cyclooxygenase. However, further studies are required to confirm the effect of Polygonum glabrum on cyclooxygenase inhi- bition. Our phytochemical investigation revealed the presence of flavonoids. Sterols are known to inhibit articular swelling, reduce the arthritis index and down regulate the content ofIL-IB and TNF-in inflamed tissues of arthritic rats. CONCLUSION The ethanolic whole plant extract of Polygonum glabrum exerts an anti-arthritic activity by significantlyaltering the pathogenesis dur- ing FCA-induced arthritis in female SD rats without exerting anyside effects. ACKNOWLEDGEMENTS The author would like to thank Management, Principal, Teaching, Non-teaching Staff of Narasaraopeta Institute of Pharmaceutical Sciences, Narasaraopet, Guntur (D.t), A.P., India for providing sup- port for successful completion of research work. REFERENCES 1. Shah Biren N, Nayak BS, Seth AK, Jalalpure SS, Patel KN, Patel MA and Mishra AD. Search for medicinal plants as a source of anti-inflammatory and anti-arthritic agents - A review. PharmacognosyMagazine, 2006; 2(6): 77-86. 2. G.S. Firestein,VIP: a veryimportant protein in arthritis, Natu- ral Medicines, 7(2001), 537–538. 3. Amdekar S, RoyP, SinghV, KumarA, Singh Rand Sharma P. Anti-Inflammatory Activity of Lactobacillus on Carrag- eenan-Induced Paw Edema in male Wistar Rats. Interna- tional Journal of Inflammation, 2012; 1-6. 4. Amritpal Singh, Samir Malhotra, Ravi subban,Anti- inflam- matoryand analgesic agents from Indian medicinal plants, International Journal ofintegrativeBiology, 2008(3):No.1,57. 5. Kumar EK, Masthan SK, Reddy KR, Reddy GA, Raghunandan N, Chaitanya G. Anti-arthritic property of the methanolic extract of Syzygium cumini seeds. Int J Integr Biol.2008;4:55–61. 6. Kilimozhi D, Parthasarathy V, Amuthavalli N. Effect of Clerodendrum phlomidis on adjuvant induced arthritis in
  • 6. Journal of Pharmacy Research Vol.10 Issue 6 June 2016 V.Satyanarayana et al. / Journal of Pharmacy Research 2016,10(6),431-436 431-436 Source of support: Nil, Conflict of interest: None Declared rats:Aradiographic densitometric analysis. Int J Pharm Tech Res. 2009;1:1434–41. 7. V Satyanarayana, S Jaya Kumari.Preliminaryphytochemical screening and TLC profile ofselected four plants ofTirupati hills in Chitoor district, Andhra Pradesh.Journal of Pharmacognosyand Phytochemistry,2016:5(2):259-264 8. Bendele A, McComb J, Gould T, McAbee T, Sennello G, Chlipala E, et al. Animal models of arthritis: Relevance to human disease. ToxicolPathol. 1999;27:134–42. 9. Newbould BB. Suppression of adjuvant-induced arthritis in rats with 2-butoxycarbonylmethylene-4- oxothiazolidine. Br JPharmacol Chemother. 1965;24:632–40. 10. Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact. 2001;1:377–85. 11. Berrington J. Biologic treatments for rheumatoid arthritis.J OrthopNurs. 2006;10:159–65. 12. Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010;1:87–93. 13. John NA, Shobana G.Anti-inflammatoryactivityofTalinum fruticosum L. on formalin induced paw edema in albino rats. JAppl Pharm Sci. 2012;2:123–7. 14. Kumar VL, RoyS. Calotropis procera latex extract affords protection against inflammation and oxidative stress in Freund’s complete adjuvant-induced monoarthritis in rats. MediatorsInflamm. 2007;2007:47523. 15. Newbould BB. Chemotherapy ofarthritis induced in rats by mycobacterial adjuvant. Br J Pharmacol Chemother. 1963;21:127–36.